Automated description from the Alliance of Genome Resources (Release 3.1)
Predicted to have phosphatidylinositol-3-phosphate binding activity; superoxide-generating NADPH oxidase activator activity; and superoxide-generating NADPH oxidase activity. Predicted to be involved in oxidation-reduction process and superoxide metabolic process. Localizes to cytoplasm. Is expressed in liver; lower urinary tract; stomach; and testis. Human ortholog(s) of this gene implicated in autosomal recessive chronic granulomatous disease cytochrome b-positive type III. Orthologous to human NCF4 (neutrophil cytosolic factor 4).